A citation-based method for searching scientific literature

Thais Leite Nascimento, Hervé Hillaireau, Juliette Vergnaud, Elias Fattal. Nanomedicine (Lond) 2016
Times Cited: 27







List of co-cited articles
75 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine.
George Mattheolabakis, Lara Milane, Amit Singh, Mansoor M Amiji. J Drug Target 2015
246
22

Hyaluronic acid for anticancer drug and nucleic acid delivery.
Franco Dosio, Silvia Arpicco, Barbara Stella, Elias Fattal. Adv Drug Deliv Rev 2016
295
18

Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells.
Walhan Alshaer, Hervé Hillaireau, Juliette Vergnaud, Said Ismail, Elias Fattal. Bioconjug Chem 2015
109
14

Hyaluronic acid-coated liposomes for active targeting of gemcitabine.
Silvia Arpicco, Carlotta Lerda, Elisa Dalla Pozza, Chiara Costanzo, Nicolas Tsapis, Barbara Stella, Massimo Donadelli, Ilaria Dando, Elias Fattal, Luigi Cattel,[...]. Eur J Pharm Biopharm 2013
96
14

Doxil®--the first FDA-approved nano-drug: lessons learned.
Yechezkel Barenholz. J Control Release 2012
14

Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity.
Elisa Dalla Pozza, Carlotta Lerda, Chiara Costanzo, Massimo Donadelli, Ilaria Dando, Elisa Zoratti, Maria Teresa Scupoli, Stefania Beghelli, Aldo Scarpa, Elias Fattal,[...]. Biochim Biophys Acta 2013
53
11

Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor.
Amélie Dufaÿ Wojcicki, Hervé Hillaireau, Thais Leite Nascimento, Silvia Arpicco, Myriam Taverna, Sandy Ribes, Mickaël Bourge, Valérie Nicolas, Amélie Bochot, Christine Vauthier,[...]. J Control Release 2012
73
11

Therapeutic nanoparticles for drug delivery in cancer.
Kwangjae Cho, Xu Wang, Shuming Nie, Zhuo Georgia Chen, Dong M Shin. Clin Cancer Res 2008
11



Cationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigens.
Yuchen Fan, Preety Sahdev, Lukasz J Ochyl, Jonathan Akerberg, James J Moon. J Control Release 2015
91
7

Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors.
Ilia Rivkin, Keren Cohen, Jacob Koffler, Dina Melikhov, Dan Peer, Rimona Margalit. Biomaterials 2010
98
7

Investigating the effect of tumor vascularization on magnetic targeting in vivo using retrospective design of experiment.
Kuo-Ching Mei, Jie Bai, Silvia Lorrio, Julie Tzu-Wen Wang, Khuloud T Al-Jamal. Biomaterials 2016
46
7



Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
Wenhao Li, Xiaoli Yi, Xing Liu, Zhirong Zhang, Yao Fu, Tao Gong. J Control Release 2016
68
7

The emerging nanomedicine landscape.
Volker Wagner, Anwyn Dullaart, Anne-Katrin Bock, Axel Zweck. Nat Biotechnol 2006
800
7

Engineered nanoparticles for drug delivery in cancer therapy.
Tianmeng Sun, Yu Shrike Zhang, Bo Pang, Dong Choon Hyun, Miaoxin Yang, Younan Xia. Angew Chem Int Ed Engl 2014
924
7

Cancer-related inflammation and treatment effectiveness.
Connie I Diakos, Kellie A Charles, Donald C McMillan, Stephen J Clarke. Lancet Oncol 2014
7

Drug delivery systems: entering the mainstream.
Theresa M Allen, Pieter R Cullis. Science 2004
7

Noble metal nanoparticle-induced oxidative stress modulates tumor associated macrophages (TAMs) from an M2 to M1 phenotype: An in vitro approach.
Ramkrishna Pal, Biswajit Chakraborty, Anupam Nath, Leichombam Mohindro Singh, Mohammed Ali, Dewan Shahidur Rahman, Sujit Kumar Ghosh, Abhishek Basu, Sudin Bhattacharya, Rathindranath Baral,[...]. Int Immunopharmacol 2016
49
7

Discovery and biological activity of 6BrCaQ as an inhibitor of the Hsp90 protein folding machinery.
Davide Audisio, Samir Messaoudi, Lukasz Cegielkowski, Jean-François Peyrat, Jean-Daniel Brion, Délphine Methy-Gonnot, Christine Radanyi, Jack-Michel Renoir, Mouâd Alami. ChemMedChem 2011
28
7


Synthesis and antiproliferative activity of novobiocin analogues as potential hsp90 inhibitors.
Davide Audisio, Délphine Methy-Gonnot, Christine Radanyi, Jack-Michel Renoir, Stéphanie Denis, Félix Sauvage, Juliette Vergnaud-Gauduchon, Jean-Daniel Brion, Samir Messaoudi, Mouad Alami. Eur J Med Chem 2014
18
11

Hsp90-targeted miRNA-liposomal formulation for systemic antitumor effect.
Subrata Kumar Pore, Ashwani Choudhary, Bhowmira Rathore, Anirban Ganguly, Pombala Sujitha, C Ganesh Kumar, Sachin Bharat Agawane, Jerald Mahesh Kumar, Vinod Scaria, Beena Pillai,[...]. Biomaterials 2013
18
11


Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.
H Maeda, J Wu, T Sawa, Y Matsumura, K Hori. J Control Release 2000
7

Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90.
Byoung Heon Kang, Janet Plescia, Ho Young Song, Massimiliano Meli, Giorgio Colombo, Kristin Beebe, Bradley Scroggins, Len Neckers, Dario C Altieri. J Clin Invest 2009
174
7


Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
7

Formulation and in vitro efficacy of liposomes containing the Hsp90 inhibitor 6BrCaQ in prostate cancer cells.
Félix Sauvage, Silvia Franzè, Alexandre Bruneau, Mouad Alami, Stéphanie Denis, Valérie Nicolas, Sylviane Lesieur, François-Xavier Legrand, Gillian Barratt, Samir Messaoudi,[...]. Int J Pharm 2016
18
11

Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
Roshan Pradhan, Thiruganesh Ramasamy, Ju Yeon Choi, Jeong Hwan Kim, Bijay Kumar Poudel, Jin Wook Tak, Natalia Nukolova, Han-Gon Choi, Chul Soon Yong, Jong Oh Kim. Carbohydr Polym 2015
32
7

Cancer-related inflammation.
Alberto Mantovani, Paola Allavena, Antonio Sica, Frances Balkwill. Nature 2008
7



Robust, Responsive, and Targeted PLGA Anticancer Nanomedicines by Combination of Reductively Cleavable Surfactant and Covalent Hyaluronic Acid Coating.
Jintian Wu, Jian Zhang, Chao Deng, Fenghua Meng, Ru Cheng, Zhiyuan Zhong. ACS Appl Mater Interfaces 2017
35
7

Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery.
Ju-Hwan Park, Hyun-Jong Cho, Hong Yeol Yoon, In-Soo Yoon, Seung-Hak Ko, Jae-Seong Shim, Jee-Hyun Cho, Jae Hyung Park, Kwangmeyung Kim, Ick Chan Kwon,[...]. J Control Release 2014
122
7

Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review.
Manju Kanamala, William R Wilson, Mimi Yang, Brian D Palmer, Zimei Wu. Biomaterials 2016
450
7

Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
Yogeshkumar Malam, Marilena Loizidou, Alexander M Seifalian. Trends Pharmacol Sci 2009
661
7

Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.
A Gabizon, A T Horowitz, D Goren, D Tzemach, F Mandelbaum-Shavit, M M Qazen, S Zalipsky. Bioconjug Chem 1999
331
7

Supramolecular Organization and siRNA Binding of Hyaluronic Acid-Coated Lipoplexes for Targeted Delivery to the CD44 Receptor.
Thais L Nascimento, Hervé Hillaireau, Magali Noiray, Claudie Bourgaux, Silvia Arpicco, Gérard Pehau-Arnaudet, Myriam Taverna, Donato Cosco, Nicolas Tsapis, Elias Fattal. Langmuir 2015
29
7

Layer-by-layer coated lipid-polymer hybrid nanoparticles designed for use in anticancer drug delivery.
Thiruganesh Ramasamy, Tuan Hiep Tran, Ju Yeon Choi, Hyuk Jun Cho, Jeong Hwan Kim, Chul Soon Yong, Han-Gon Choi, Jong Oh Kim. Carbohydr Polym 2014
109
7

Applications of nanoparticles for diagnosis and therapy of cancer.
S C Baetke, T Lammers, F Kiessling. Br J Radiol 2015
190
7

Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.
Thomas J Anchordoquy, Yechezkel Barenholz, Diana Boraschi, Michael Chorny, Paolo Decuzzi, Marina A Dobrovolskaia, Z Shadi Farhangrazi, Dorothy Farrell, Alberto Gabizon, Hamidreza Ghandehari,[...]. ACS Nano 2017
162
7

Applications of lipid nanoparticles in gene therapy.
Ana Del Pozo-Rodríguez, María Ángeles Solinís, Alicia Rodríguez-Gascón. Eur J Pharm Biopharm 2016
55
7

Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
Ankit Saneja, Debasis Nayak, M Srinivas, Amit Kumar, Vaibhav Khare, Archana Katoch, Anindya Goswami, Ram A Vishwakarma, Sanghapal D Sawant, Prem N Gupta. Eur J Pharm Sci 2017
25
8

Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies.
Sanjun Shi, Min Zhou, Xin Li, Min Hu, Chenwen Li, Min Li, Fangfang Sheng, Zhuoheng Li, Guolin Wu, Minghe Luo,[...]. J Control Release 2016
51
7

Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer.
Suniti Misra, Vincent C Hascall, Roger R Markwald, Shibnath Ghatak. Front Immunol 2015
422
7

Perspectives of CD44 targeting therapies.
V Orian-Rousseau, H Ponta. Arch Toxicol 2015
75
7

Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.
Bryan P Toole, Mark G Slomiany. Drug Resist Updat 2008
137
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.